Gabapentin Capsule
Product Images NDC 83301-0005

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 83301-0005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (100mg Labels 1000capsules)

Label for Gabapentin Capsules USP, 100 mg strength, in a 1,000 capsule package. Manufactured for Mullan Pharmaceutical Inc. The label includes dosage form as capsules, oral route, and storage instructions. Manufacturer details show CSPC Ouyi Pharmaceutical Co., Ltd. located in China. The label contains NDC 83301-0003-3 and barcodes.*

FDA Label Image

Image Description (100mg Labels 100capsules)

Label for Gabapentin Capsules USP 100 mg by Mullan Pharmaceutical Inc. The label specifies a 100 capsule count and includes storage instructions, manufacturer details, and an NDC of 83301-0003-1. It features the dosage strength prominently in a green box and states the product is Rx only.*

FDA Label Image

Image Description (100mg Labels 500capsules)

Gabapentin Capsules USP 100 mg oral capsules label from Mullan Pharmaceutical Inc., showing the NDC 83301-0003-2. The label indicates a package size of 500 capsules and includes dosage, storage instructions, and manufacturer information for CSPC Ouji Pharmaceutical Co., Ltd. The label cautions pharmacy dispensing with accompanying medication guide and Rx only status.*

FDA Label Image

Image Description (300mg Labels 1000capsules)

Label for Gabapentin Capsules USP, 300 mg strength, containing 1,000 oral capsules. Manufactured for Mullan Pharmaceutical Inc. in Pasadena, CA and by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China. Includes storage instructions, pharmacist dispensing note, and NDC 83301-0004-3.*

FDA Label Image

Image Description (300mg Labels 100capsules)

Label for Gabapentin Capsules USP, 300 mg strength, with a quantity of 100 capsules. The label includes the National Drug Code (NDC) 83301-0004-1, manufacturer information listing Mullan Pharmaceutical Inc. and CSPC Ouyi Pharmaceutical Co., Ltd., and storage instructions. The label is white with black text, featuring the 300 mg strength highlighted in an orange box.*

FDA Label Image

Image Description (300mg Labels 500capsules)

Label for Gabapentin Capsules, USP, 300 mg strength, oral dosage form. The label states the package contains 500 capsules. It includes storage instructions and manufacturer information: manufactured by CSPC Ouyi Pharmaceutical Co., Ltd., and for Mullan Pharmaceutical Inc. It features an NDC code 83301-0004-2, a barcode, and pharmacist dispensing instructions.*

FDA Label Image

Image Description (400mg Labels 1000capsules)

Label for Gabapentin Capsules USP, 400 mg strength, in a package of 1,000 capsules. The label includes storage instructions, dosage information reference, and manufacturer details for Mullan Pharmaceutical Inc., Pasadena, CA. The label also shows a barcode and logos for Mullan Pharmaceutical and CSPC.*

FDA Label Image

Image Description (400mg Labels 100capsules)

The label for Gabapentin Capsules USP features the 400 mg strength prominently. It specifies 100 capsules in the package and includes storage instructions and manufacturer information. The labeler is Mullan Pharmaceutical Inc. The label shows NDC 83301-0005-1 and includes a barcode and logos for Mullan and CSPC.*

FDA Label Image

Image Description (400mg Labels 500capsules)

Label for Gabapentin Capsules USP 400 mg in a container of 500 capsules. The label includes the NDC 83301-0005-2 and states it is manufactured for Mullan Pharmaceutical Inc. The label provides storage instructions, dosage form as capsules, and mentions the product is Rx only. The label features logos for Mullan and CSPC.*

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure of Gabapentin, shown as a molecular diagram with a cyclohexane ring and attached functional groups representing amine and carboxylic acid groups.*

FDA Label Image

Figure 1 (Gabapenin 02)

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3,600 mg/day groups. The x-axis represents weeks from baseline to week 8, while the y-axis shows mean pain scores from 0 to 10. The graph distinguishes a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin group showing decreasing pain scores over time compared to placebo.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph showing mean pain scores over a period of 7 weeks comparing placebo and two doses of gabapentin (1,800 mg/day and 2,400 mg/day). The timeline is divided into a 3-week dose titration period followed by a 4-week fixed dose period, with mean pain scores plotted on the y-axis and weeks on the x-axis.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart comparing two studies showing percentage outcomes for placebo (PBO) and Gabapentin (GBP) at different dosages. Study 1 compares PBO to GBP 3,600 mg, and Study 2 compares PBO to GBP 1,800 mg and GBP 2,400 mg, with statistical significance indicated for GBP groups.*

FDA Label Image

Figure 4 (Gabapenin 05)

A chart depicting the percentage difference versus daily dose (mg) of Gabapentin across three studies labeled a, b, and c. The chart shows data points at doses ranging approximately from 600 mg to 1800 mg, with percentage differences from about 2% to 22%. Each study is represented by different colored squares, comparing outcomes by daily dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.